These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1367 related items for PubMed ID: 19041120

  • 1. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Jia de A, Cao Z, Nie B, Ge HL, Yang SW, Yan ZX.
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [Abstract] [Full Text] [Related]

  • 2. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
    Tavassoli N, Voisin S, Carrie D, Lapeyre-Mestre M, Galinier M, Montastruc JL, Pathak A.
    Am J Cardiovasc Drugs; 2010 May; 10(1):29-35. PubMed ID: 20104932
    [Abstract] [Full Text] [Related]

  • 3. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
    Migliorini A, Valenti R, Marcucci R, Parodi G, Giuliani G, Buonamici P, Cerisano G, Carrabba N, Gensini GF, Abbate R, Antoniucci D.
    Circulation; 2009 Dec 01; 120(22):2214-21. PubMed ID: 19917884
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E.
    Am J Cardiol; 2009 Nov 15; 104(10):1357-61. PubMed ID: 19892050
    [Abstract] [Full Text] [Related]

  • 5. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
    Han YL, Wang B, Li Y, Xu K, Wang SL, Jing QM, Wang ZL, Wang DM, Ma YY, Wang G.
    Chin Med J (Engl); 2009 Apr 05; 122(7):793-7. PubMed ID: 19493391
    [Abstract] [Full Text] [Related]

  • 6. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2312-7. PubMed ID: 17572245
    [Abstract] [Full Text] [Related]

  • 7. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P, Bonello L, Torguson R, Okabe T, Pinto Slottow TL, Steinberg DH, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Mar 15; 103(6):801-5. PubMed ID: 19268735
    [Abstract] [Full Text] [Related]

  • 8. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM, Claeys MJ, Haine S, Miljoen H, Bosmans JM, Vertessen F, Kluppels K, Van der Planken M, Vrints CJ.
    Am Heart J; 2010 Mar 15; 159(3):434-8. PubMed ID: 20211306
    [Abstract] [Full Text] [Related]

  • 9. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A, Amit G, Cafri C, Gilutz H, Ilia R, Zahger D.
    Int J Cardiol; 2005 Sep 01; 103(3):293-7. PubMed ID: 16098392
    [Abstract] [Full Text] [Related]

  • 10. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
    Sibbing D, Morath T, Braun S, Stegherr J, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.
    Thromb Haemost; 2010 Jan 01; 103(1):151-9. PubMed ID: 20062919
    [Abstract] [Full Text] [Related]

  • 11. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation.
    Geisler T, Langer H, Wydymus M, Göhring K, Zürn C, Bigalke B, Stellos K, May AE, Gawaz M.
    Eur Heart J; 2006 Oct 01; 27(20):2420-5. PubMed ID: 17005534
    [Abstract] [Full Text] [Related]

  • 12. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

  • 13. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P, Windecker S, Cook S, Billinger M, Togni M, Garachemani A, Meier B, Hess OM, Wenaweser P.
    Am Heart J; 2010 May 13; 159(5):891-898.e1. PubMed ID: 20435201
    [Abstract] [Full Text] [Related]

  • 14. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Wang ZJ, Zhou YJ, Liu YY, Yu M, Shi DM, Zhao YX, Guo YH, Cheng WJ, Nie B, Ge HL, Jia DA, Yang SW, Yan ZX.
    Heart; 2009 Oct 13; 95(19):1587-92. PubMed ID: 19592387
    [Abstract] [Full Text] [Related]

  • 15. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
    Lemesle G, Delhaye C, Sudre A, Broucqsault D, Rosey G, Bauters C, Lablanche JM.
    Am Heart J; 2009 Feb 13; 157(2):375-82. PubMed ID: 19185648
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.
    Circulation; 2009 Jan 20; 119(2):237-42. PubMed ID: 19118249
    [Abstract] [Full Text] [Related]

  • 17. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):27-33. PubMed ID: 16386660
    [Abstract] [Full Text] [Related]

  • 18. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.
    J Am Coll Cardiol; 2009 Mar 10; 53(10):849-56. PubMed ID: 19264241
    [Abstract] [Full Text] [Related]

  • 19. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB, Wiviott SD, Buros JL, Zorkun C, Tariq MU, Antman EM, Braunwald E, Gibson CM, TIMI Study Group.
    Am Heart J; 2009 Sep 10; 158(3):e21-6. PubMed ID: 19699846
    [Abstract] [Full Text] [Related]

  • 20. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S, Hoffmeister HM, Bode C.
    Herz; 2008 Jun 10; 33(4):244-53. PubMed ID: 18581073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.